Web Analytics

3 Latest Announced Rounds

  • $7,500,000
    Seed

    2 Investors

    Software Development
    Nov 21st, 2024
  • $6,000,000
    Series A

    1 Investors

    Transportation, Logistics, Supply Chain and Storage
    Nov 21st, 2024
  • $30,000,000
    Unknown

    1 Investors

    Financial Services
    Nov 21st, 2024
$1,631.41M Raised in 96 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Carmot Therapeutics, Inc.

start up
United States - Berkeley
  • 26/07/2022
  • Series D
  • $160,000,000

Carmot Therapeutics, Inc. is a clinical-stage company dedicated to the discovery and development of innovative medicines. Carmot applies a transformative, patented drug discovery approach, Chemotype Evolution to explore novel frontiers of chemistry and biology. Using Chemotype Evolution, Carmot has developed a portfolio of drug candidates in metabolic disease and oncology.


Related People

Stig HansenCo Founder

Stig Hansen United States - Berkeley, California

NA